|
|
Spring Meeting Giovani Ricercatori SID-SIIA-SIMI-SIPREC-SISA 2023
Presentazione dei poster: 4+4 min
Poster: layout verticale 70x100 cm
I poster vanno stampati e appesi negli spazi indicati
|
|
|
|
|
|
|
|
Domenica 16 Aprile 2023
|
|
|
|
18.30-19.30
|
Sessione Poster 1
Nuovi approcci diagnostici-terapeutici nelle malattie cardiometaboliche
Moderatore: Massimiliano Cavallo
1 - Accuracy of CHADS2, CHA2DS2-VASC and HAS-BLED and Machine Learning models in predicting stroke/TIA and major bleedings, in critically-ill patients with non-valvular atrial fibrillation
• Guerrieri Emanuele
2 - The diagnostic accuracy of non-invasive tests of fibrosis in patients with metabolic associated fatty liver disease. A multicentric comparative study between liver biopsy and non-invasive scores or Fibroscan
• Cespiati Annalisa
3 - Reclassification with ABI and carotid ultrasound of multivascular involvement in Cardiological Rehabilitation
• Pezzoli Stefano
4 - Acute ischemic stroke: how to investigate the association between disease etiology and gene expression profiles
• Cassioli Giulia
5 - Clinical usefulness and prognostic value of lung ultrasound in heart failure
• Perillo Andrea
6 - Sex-based analysis of the efficacy of a mobile health technology integrated care in patients with atrial fibrillation: insights from a cluster randomised trial
• Corica Bernadette
7 - Normalization of ascending aorta dimension for body size influences pathophysiologic correlation in hypertensive patients: the Campania Salute Network
• Basile Christian
|
|
|
|
18.30-19.30
|
Sessione Poster 2
COVID-19 dalla fisiopatologia alle complicanze con impatto cardiometabolico
Moderatore: Giovanni Talerico
1 - Treatment with allopurinol attenuates the detrimental impact of systemic inflammation on endothelial function in patients with COVID-19
• Ricciutelli Federica
2 - NLRP3 inflammasome-related exosomal miRNAs are associated with radiologic sequelae in survivors of COVID-associated acute respiratory distress syndrome
• Curcio Rosa
3 - Correlation between coagulation activation and pulmonary changes detected by lung ultrasound in COVID-19 patient
• Boccatonda Andrea
4 - Identification of rare coagulation variants and screening of polymorphisms F2 rs1799963 and F5 rs6025 in COVID-19 patients
• Giannini Marco
5 - Cardiovascular risk and outcomes in the post-covid syndrome
• Santini Silvia
6 - Individual vulnerability to SARS-COV-2 infection: genetic profiles and the role of the host’s virus entry machine
• Squillantini Lapo
7 - Block of the angiotensin pathways effects flow-volume spirometry in patients with SARS-CoV-2 infection
• Marozzi Marialuisa Sveva
|
|
|
|
18.30-19.30
|
Sessione Poster 3
Infiammazione e immunità al crocevia tra trombosi, aterosclerosi e malattie metaboliche
Moderatore: Simonetta Lugari
1 - Vaccine-induced thrombotic thrombocytopenia (VITT): evaluation of immunologic and functional tests on an Italian case series
• Bertelli Alessia
2 - Vaccine induced thrombotic thrombocytopenia (VITT): evaluation of genetic susceptibility throught WES
• Capezzuoli Tommaso
3 - Impact of immune system humanization on atherosclerosis in dyslipidemic Rag2-KO/IL2rg-KO/CD47-KO/LDL-R KO mice
• Nour Jasmine
4 - Impact of a NDUFC2 variant on the occurrence of acute coronary syndromes
• Pidone Chiara
5 - Impact of the increase in left ventricular mass on the risk of long-term cardiovascular mortality: a prospective cohort study
• Vanoli Jennifer
6 - Epigenetic regulation of NF-κB p65 in women with gestational diabetes and their offspring
• Di Pietrantonio Nadia
7 - Platelets behavior in metabolic patients affected by hepatic steatosis/steatohepatitis and liver cirrhosis
• Zoncapè Mirko
|
|
|
|
18.30-19.30
|
Sessione Poster 4
Biomarcatori emergenti: significato diagnostico e prognostico
Moderatore: Giovanna Gallo
1 - The adipokine, asprosin, as modulator of obesity metabolic complications
• Catalano Federica
2 - Visit-to-visit variability of LDL-C predicts carotid intima-media thickness
• Colangelo Cecilia
3 - Inappropriately elevated plasma leptin levels identify individuals with more severe metabolic adiposity-related complications
• Chiriacò Martina
4 - Irisin administration restores beta-cell functional mass in a mouse model of type 2 diabetes
• Borrelli Anna
5 - Uric acid significantly correlates with the presence of low-voltage areas at the endocardial mapping in patients with non-valvular atrial fibrillation
• Ciampi Claudio Mario
6 - Uric acid relationships with lipid profile and adiposity indices: impact of different hyperuricemic tresholds
• Matarrese Rossana
7 - Evaluation of HDL-bound long non-coding RNAs in subjects with familial hypercholesterolemia
• Di Giacomo Barbagallo Francesco
|
|
|
|
|
|
|
Lunedì 17 Aprile 2023
|
|
|
|
|
10.40-11.40
|
Sessione Poster 5
Ruolo della dieta nel rischio cardiometabolico
Moderatore: Costantino Mancusi
1 - Long-term dietary fats reduction attenuates the inflammatory potential of postprandial lipoproteins
• Mattavelli Elisa
2 - Micellar Lycopene as Natural Treatment for Liver Steatosis
• Mare Rosario
3 - Coffee consumption relates to a reduction of aortic stiffness in well-controlled hypertensives
• Vacca Antonio
4 - Metabolic effects of early Time-Restricted Carbohydrate consumption
• Nesti Giulia
5 - PUFA and MUFA-rich food deficiency in patients with nonalcoholic fatty liver disease
• Bianco Rossella
6 - Insulin Prevents Palmitate-Induced Stress Kinase Activation, Autophagy and Apoptosis in Human Cardiac Progenitor Cells
• Calderoni Isabella
|
|
|
|
10.40-11.40
|
Sessione Poster 6
Dislipidemie primitive: dalla diagnosi alla terapia
Moderatore: Manuela Casula
1 - The complexity of diagnosis of a rare disease: the case of a suspected Fabry disease
• Carosi Martina
2 - Successful treatment with lomitapide in a patient with homozygous familial hypercholesterolemia and severe fatty liver disease
• Cavicchioli Alessia
3 - A border-line clinical expression in a patient with compound heterozygous mutation (LDLR/PCSK9): what is the best management?
• Ricciardi Riccardo Mattia
4 - Two sisters with severe hypertriglyceridemia caused by APOA5 biallelic variants
• Ferrandino Martina
5 - Novel missense variants in the lmf1 gene: identification by next generation sequencing and functional characterization
• Fasciana Teresa Maria Grazia
6 - Identification of a novel nonsense mutation in the apob gene by next generation sequencing
• Lanza Marina
|
|
|
|
10.40-11.40
|
Sessione Poster 7
NAFLD & MAFLD
Moderatore: Sebastiano Cicco
1 - Optimization of glucose control drives improvement of NAFLD independent of weight loss in people with T2D
• Colosimo Santo
2 - Risk of atherosclerotic diseases in hypertensive patients with NAFLD and sleeping disorders
• Gramegna Davide
3 - Metabolic associated fatty liver disease (MAFLD) and its features: different impact on the hepatic and cardiovascular complications
• Santomenna Floriana
4 - Insulin resistance predicts advanced liver fibrosis in subjects with obesity and Metabolic dysfunction-Associated Fatty Liver Disease (MAFLD)
• Petralli Giovanni
5 - Prevalence of portal vein thrombosis in non-alcoholic fatty liver disease: a meta-analysis of observational studies
• Stupia Roberta
6 - Misperception of dietary regimens in patients with nonalcoholic fatty liver disease
• De Girolamo Giuseppe
7 - Liver fibrosis is associated with an increased risk of non-fatal acute myocardial infarction
• Vero Laura
|
|
|
|
10.40-11.40
|
Sessione Poster 8
Trattamenti farmacologici in ambito cardiovascolare: from bench to bedside
Moderatore:Antonella Giammanco
1 - Effect of lipid-lowering therapies on lipoprotein(a) levels: a meta-analysis of randomized controlled trials
• Xie Sining
2 - Safety and effectiveness of oral anticoagulants in patients with atrial fibrillation and severe renal failure
• Talerico Rosa
3 - Edoxaban effects on platelet function: in vitro and ex vivo studies
• Barbieri Giulia
4 - Statin-Associated Muscle Symptoms – Clinical Index in a hypertensive population candidated to lipid-lowering therapy but not taking statins
• Alessandroni Romina
5 - Impact of glycaemic control on cardiovascular outcomes and mortality in a cohort of patients with type 2 diabetes mellitus in a multifactorial randomized controlled trial
• Caturano Alfredo
6 - Use of combination treatment in hypertension management and its association with hypertension control
• Croce Alessandro
7 - Role of concomitant chronic therapies on adherence to cardiovascular treatments
• Scotti Stefano
|
|
|
|
|
|
|
Martedì 18 Aprile 2023
|
|
|
|
|
10.30-11.30
|
Sessione Poster 9
Molecole chiave nella regolazione del metabolismo lipoproteico: aspetti emergenti
Moderatore: Alessandro Maloberti
1 - ApoA-I deletion or overexpression in apoE deficient mice alters lipid deposition in peripheral tissues
• Franchi Elsa
2 - Development of novel PCSK9 inhibitors as pharmacological approaches for the treatment of alzheimer’s disease: in vitro and in vivo studies
• Ugolotti Martina
3 - PCSK9: A New Marker of Cardiovascular Risk in Post-menopausal Diabetic Women in Primary Prevention
• Orlando Luana
4 - ANGPTL3 and PCSK9 interact and show coordinated metabolic regulation in vitro
• Bini Simone
5 - PCSK9 interacts with a subspecies of LDL with IDL-like characteristics
• Matteucci Sara
6 - In vitro silencing of ANGPTL3 increases lipid accumulation in hepatic Huh7 cell line
• Rossi Ilaria
7 - Injection site reaction to Alirocumab and Evolocumab in a young woman with familial hypercholesterolemia: a possible cell-mediated hypersensitivity to polysorbate and an effective therapeutic alternative based on Inclisiran
• Di Agostini Angelica
|
|
|
|
10.30-11.30
|
Sessione Poster 10
Assi cuore-rene, cuore-fegato e cuore-intestino
Moderatore: Alice Ossoli
1 - Renal denervation in patients with resistant hypertension: follow up 2011-2021 of the series of the ESH center of excellence in Turin
• Ponsa Lara
2 - Association of kidney function impairment and coronary artery disease severity
• Di Gioia Giuseppe
3 - Factor associated with hyperuricemia development during a 25 years follow-up: the PAMELA Study
• Camedda Giammarco
4 - Adrenal incidentaloma
• Sconfienza Elisa
5 - Metabolic Syndrome and its components predict the development of Arterial Stiffening in a sample of adult men – The OLIVETTI Heart Study
• Pizzulo Ilaria Libera
6 - Cardiovascular risk, metabolic profile and inflammatory fingerprint of obese subjects who underwent bariatric surgery
• Burrello Jacopo
7 - Metabolic crosstalk between adipose tissue and β-cells in youths with primary insulin hypersecretion
• Tricò Domenico
|
|
|
|
10.30-11.30
|
Sessione Poster 11
Malattia cardiovascolare: quando si verifica il raro e l’inatteso…
Moderatore: Francesco Spannella
1 - Le emergenze ipertensive: i dati della pratica clinica a confronto con le indicazioni delle linee guida
• De Censi Lorenzo
2 - Hypertensive emergencies and urgencies: blood pressure management and its relationship with short and medium term outcome.
• Garofani Ilaria
3 - Extreme cardiovascular risk in cardiological rehabilitation: prevalence and impact on patient’s functional improvement
• Riccio Alfonso
4 - Acupuncture in arterial hypertension: evaluation of its efficacy with both office and ambulatory blood pressure measurements
• Caccia Andrea
5 - Natural history and clinical burden of moderate aortic stenosis: a systematic review and meta-analysis
• Morelli Martina
6 - A not-so-rare complication of connective tissue disease
• Bonadies Davide
|
|
|
|
10.30-11.30
|
Sessione Poster 12
Chiedi all’esperto…
Moderatore: Arturo Cesaro
1 - Change over time of lipid profile relates to steroid treatment but not to an inflammatory state in Granulomatosis with poliangioitis polyangiitis (GPA)
• Cicco Sebastiano
2 - Does the lipoprotein(a) genotype influence the diagnosis of familial hypercholesterolemia?
• Casula Manuela
3 - The Impact of Clinical Complexity and integrated care management in patients with Atrial Fibrillation: insights from an European-wide prospective registry
• Romiti Giulio Francesco
4 - Lysosomal acid lipase (LAL) deficiency alters immune cells distribution in humans and mice
• Bonacina Fabrizia
|
|
|
|
|
|
|
